Document Detail


A consensus report on antiarrhythmic drug use.
MedLine Citation:
PMID:  8168278     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
During the past few years, a number of new antiarrhythmic agents have become available for use in the United States, encainide has been withdrawn from use, and others have had indications for use modified. Therefore, a meeting of arrhythmia specialists was convened in an attempt to develop guidelines for antiarrhythmic therapy. The resultant discussions and guidelines presented in this article address general issues such as the most important antiarrhythmic drug attributes, as well as therapy for particular arrhythmias such as premature ventricular contractions, ventricular tachycardia, ventricular fibrillation, ventricular ectopy, and supraventricular tachyarrhythmias.
Authors:
J A Reiffel; N A Estes; A L Waldo; E N Prystowsky; R DiBianco
Related Documents :
18984528 - Ventricular arrhythmias originating from a papillary muscle in patients without prior i...
2456168 - Spontaneous variability of simple and complex ventricular premature contractions during...
3252968 - The lambeth conventions: guidelines for the study of arrhythmias in ischaemia infarctio...
10683358 - Prevention of high incidence of neurally mediated ventricular arrhythmias by afferent n...
12436028 - Magnesium-enriched coronary sinus retroperfusion during acute coronary artery occlusion.
735848 - Left ventricle of the heart on conventional lateral chest films.
Publication Detail:
Type:  Consensus Development Conference; Journal Article; Review    
Journal Detail:
Title:  Clinical cardiology     Volume:  17     ISSN:  0160-9289     ISO Abbreviation:  Clin Cardiol     Publication Date:  1994 Mar 
Date Detail:
Created Date:  1994-06-01     Completed Date:  1994-06-01     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7903272     Medline TA:  Clin Cardiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  103-16     Citation Subset:  IM    
Affiliation:
Department of Medicine, Columbia Presbyterian Medical Center, New York, New York 10032.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Arrhythmia Agents / adverse effects,  classification,  therapeutic use*
Arrhythmias, Cardiac / drug therapy
Humans
Risk Factors
Tachycardia, Supraventricular / drug therapy
Tachycardia, Ventricular / drug therapy
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anomalous origin of the circumflex coronary artery from the right sinus of Valsalva as a cause of is...
Next Document:  Importance of serum anticardiolipin antibody levels in coronary heart disease.